FDA WARNING_LETTER - Corporacion Avicola Morovis Inc - March 25, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected Corporacion Avicola Morovis, Inc.'s shell egg production facility from March 17-25, 2014, finding serious violations of the Prevention of Salmonella Enteritidis (SE) in Shell Eggs regulation (21 CFR 118). These violations render their shell eggs adulterated under the FD&C Act and in violation of the PHS Act.
Key violations include: 1. **Inadequate SE Prevention Plan (21 CFR 118.4):** * Failure to include practices protecting against cross-contamination when persons move between poultry houses (e.g., footbaths, hand sanitizing), and observed lack of such practices with stray animals and excrement present. * Failure to include and implement measures preventing stray poultry, wild birds, cats, and other animals from entering poultry houses; observed numerous wild birds, nesting, feeding, and leaving excrement, and cattle on manure pits due to lack of barriers. * Failure to prohibit employees from keeping birds at home in the written plan. * Failure to include and implement an appropriate fly monitoring method (e.g., spot cards, Scudder grills, sticky traps) and use appropriate control methods when needed. * Failure to include the requirement that chicks be procured from SE-monitored breeder flocks meeting NPIP "U.S. S. Enteritidis Clean" status.
ID · b7752d4c-7497-4942-9c46-36b5adda549d
Full citation text and observation details available on the Dashboard.